Document:

EX-10.8

 Exhibit 10.8 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT is entered into as of July 23, 2021 (this “Agreement”), by and between
WCG Clinical, Inc., a Delaware corporation (the “Company”), and Laurie Jackson, an individual (“Employee”). 

WHEREAS, Employee entered into an Employment Agreement with an affiliate of the Company dated as of June 11, 2012 (the
“Original Agreement”); and 
 WHEREAS, Employee and the Company desire to amend and restate the Original Agreement
in its entirety pursuant to the terms of this Agreement to set forth the terms and conditions of Employee’s continued employment with the Company. 

NOW, THEREFORE, in consideration of the premises and of the respective representations, warranties, covenants and agreements contained
herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1.
Employment. 
 (a) The Company or one of its affiliates hereby agrees to employ Employee, and Employee hereby accepts such
employment, as the Chief Financial Officer and Chief Administrative Office for the Company, with such duties and responsibilities as shall be set forth by the Chief Executive Officer of the Company (the “CEO”) or the Board of
Directors of the Company, or any designee(s) thereof (collectively, the “Board”). To the extent necessary to meet the Company’s business goals, the CEO or the Board may modify Employee’s duties or assign new duties to
Employee or modify Employee’s reporting relationships. Employee shall devote all of her business time, attention, and efforts to the performance of Employee’s duties hereunder. Notwithstanding the foregoing, Employee may provide services
as a volunteer or director to charitable, educational or civic organizations; act as a member, director or officer of any industry trade association or group; and may serve as a trustee, director or advisor to any family companies or trusts;
provided that, in all cases, such services or acts shall not, in the reasonable judgment of the CEO or Board, interfere or be likely to interfere with Employee’s ability to discharge Employee’s duties and responsibilities to the Company.
Employee shall faithfully adhere to, execute, and fulfill all lawful policies established by the Company. 
 (b) As consideration for the
services performed by Employee, the Company shall pay Employee a base salary, at the annual rate of $435,000 (“Base Salary”), payable in installments at such times as the Company customarily pays its other executives (but in any
event no less often than monthly). In addition to her Base Salary, Employee shall be eligible to receive an annual incentive bonus in an amount up to fifty percent (50%) of Employee’s Base Salary (the “Incentive Bonus”) in the
sole discretion of the Board. The applicable criteria for achieving an Incentive Bonus shall be established by the Board, in its or their sole discretion. So long as Employee remains employed by the Company, the Company will provide benefits to
Employee no less favorable than those benefits made available generally to similarly situated employees of the Company. The Company may withhold from any amounts payable under this Agreement such federal, state, and local taxes as may be required to
be withheld pursuant to any applicable law or regulation. The Company agrees that Employee’s Base Salary and performance will be reviewed at least annually by the Board to determine if an increase in compensation is appropriate, which increase
shall be in the sole discretion of the Board. 
 (c) Employee shall be entitled to paid time off annually in accordance with Company
policies. 

  
 1 

 (d) The Company or one of its affiliates agrees to reimburse Employee for all reasonable
business travel and other out-of-pocket expenses incurred by Employee in the discharge of Employee’s duties hereunder, subject to the Company’s reimbursement
policies in effect from time to time. In addition, the Company will reimburse Employee for dues necessary for him to renew and maintain membership in industry associations or organizations and to subscribe to industry publications, in each case
subject to the prior written approval of the Company or the Board, in its or their sole discretion. All reimbursable expenses shall be appropriately documented in reasonable detail by Employee upon submission of any request for reimbursement, and in
a format and manner consistent with the Company’s expense reporting policy, as may be in effect from time to time, as well as applicable federal and state record keeping requirements. 

2. Termination. 
 (a)
Employee’s employment with the Company is at-will, and Employee’s employment with the Company can be terminated by the Company for any reason, with or without cause. The foregoing notwithstanding, in
consideration of the benefits conferred in this Section 2, Employee agrees to provide the Company with thirty (30) days’ written notice in advance of Employee’s voluntary resignation, including the identity of Employee’s
prospective new employer, if any. 
 (b) Upon termination of this Agreement for any reason, Employee (or Employee’s estate or personal
representative, as applicable) shall be entitled to receive (i) all of Employee’s accrued but unpaid Base Salary through the effective date of termination, whereafter no further Base Salary shall accrue, and (ii) reimbursement of any
proper expenses in accordance with Section 1(d). 
 (c) In the event that the Company terminates Employee’s
employment without Cause (as defined below) or Employee resigns for Good Reason (as defined below), Employee shall be entitled to receive the Severance Payment (as defined below); provided, however, that Employee’s receipt of the Severance
Payment is expressly conditioned on Employee’s execution and non-revocation of a general release and waiver of any and all claims against the Company arising out of her employment or termination thereof
in form and substance specified by and acceptable to the Company (the “Separation Release”). The Salary Portion (as defined below) of the Severance Payment will be paid to Employee as follows: a first payment, which will cover the
first two months of Employee’s severance, will be paid to Employee in a lump sum cash payment on the sixtieth (60th) day following Employee’s separation date, provided that Employee has executed, submitted to the Company, and not revoked
the Separation Release and the revocation period for the Separation Release has expired, and the remaining amount of the Salary Portion of the Severance Payment will be paid to Employee in accordance with the Company’s normal payroll practices
following such sixtieth (60th) day for the remainder of the period in which the Severance Payment is payable. “Severance Payment” means twelve (12) months of Employee’s Base Salary at the rate in effect as of
Employee’s separation date (the “Salary Portion”) and continued coverage by the Company of Employee, her spouse and eligible dependents on its medical plan, to the extent covered under such plan immediately prior to
Employee’s termination date, for twelve (12) months, at the same premium rates that are charged to current employees receiving the same coverage; provided that (i) such continuation coverage shall cease to apply if Employee does not
pay the applicable monthly premium or if Employee is eligible to receive other coverage from her new employer or pursuant to her spouse’s plan, (ii) the COBRA continuation period shall run currently with the severance period, so that, for
such continuation coverage benefit to apply, Employee must elect COBRA continuation coverage at the time of her termination of employment, and (iii) in the event that the Company determines in its discretion that it is not practicable or
possible to continue to provide such medical or dental benefits, the Company shall pay Employee for the cost of replacing such benefits on an after-tax basis. 

  
 2 

 (d) “Cause” shall mean (i) conviction of Employee of any felony, or
the conviction of Employee of a misdemeanor which involves moral turpitude, or the entry by Employee of a plea of guilty or nolo contendere with respect to any of the foregoing, (ii) the commission of any act or failure to act by
Employee that involves moral turpitude, dishonesty, theft, destruction of property, fraud, embezzlement or unethical business conduct, or that otherwise causes material injury to the Company or any of its affiliates, whether financially or
otherwise, (iii) any breach by Employee of any rule or policy of the Company or any of its affiliates, and the failure of Employee to cure such violation (to the extent such violation is capable of being cured) under this clause
(iii) within twenty (20) days after receipt of written notice from the Company, (iv) any breach by Employee of the requirements of any other contract or agreement between the Company (or any of its affiliates) and such Employee,
including this Agreement, and the failure of Employee to cure such breach (to the extent such breach is capable of being cured) under this clause, or (v) within ten (10) days after receipt of written notice from the Company, in each case,
with respect to clauses (i) through (iv), as determined in good faith by the Board in the exercise of its reasonable business judgment. Additionally, and solely for these purposes, Employee’s dismissal by Company on account of death or
disability will not be deemed a dismissal without Cause. 
 (e) Employee shall have the right to terminate her employment for Good Reason.
For purpose of this Agreement, “Good Reason” shall be limited to the following (unless Employee and the Company shall execute a written agreement specifically stating that the occurrence of such event shall not constitute “Good
Reason” under this Agreement): (i) a material reduction in Employee’s base salary, other than as part of a reduction plan affecting all of the Company’s leadership team that is instituted as a result of economic circumstances;
(ii) a material breach by the Company of this Agreement, or (iii) a material diminution in the duties and authority of Employee. Notwithstanding the foregoing, a termination by Employee for Good Reason shall exist only if Employee provides
written notice to the Company specifying in reasonable detail the events or conditions that give Good Reason and Employee provides such notice to the Company within ninety (90) days after such events or conditions first arise. Within thirty
(30) days after notice has been received, the Company shall have the opportunity, but shall not have the obligation, to cure such events or conditions that give Good Reason. If the Company does not cure such events or conditions within the
thirty (30) day period, Employee must voluntarily terminate her employment within thirty (30) days of the expiration of the cure period. 

(f) In the event of the death of Employee during the term of Employee’s employment with the Company, this Agreement shall automatically
terminate, and the Company shall have no further obligations hereunder except as provided in Section 2(e). 
 (g)
Upon termination of this Agreement for any reason, Employee (or Employee’s estate or personal representative, as applicable) shall be entitled to receive (i) all of Employee’s accrued but unpaid Base Salary through the effective date
of termination, whereafter no further Base Salary shall accrue, and (ii) reimbursement of any proper expenses in accordance with Section 1(d). 

3. Withholding Taxes. The Company may withhold from any amounts payable under this Agreement such federal, state and local taxes as may
be required to be withheld pursuant to any applicable law or regulation. Employee shall bear all expense of, and shall be solely responsible for, any and all taxes associated with the compensation and benefits provided under this Agreement. 

4. Section 409A of the Code. 
 (a)
General. Notwithstanding the other provisions hereof, this Agreement is intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), to
the extent applicable, and shall be interpreted to avoid any penalty sanctions under Section 409A. Accordingly, all provisions herein, or incorporated by reference, shall be construed and interpreted

  
 3 

 
to comply with Section 409A and, if necessary, any such provision shall be deemed amended to comply with Section 409A and regulations thereunder. If any payment or benefit cannot be
provided or made at the time specified herein without incurring sanctions under Section 409A, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not be imposed. All payments to be
made upon a termination of employment under this Agreement that are deferred compensation may only be made upon a “separation from service” under Section 409A. For purposes of Section 409A, each payment made under this Agreement
shall be treated as a separate payment. In no event may Employee, directly or indirectly, designate the calendar year of payment. 
 (b)
Payment Delay. To the maximum extent permitted under Section 409A, the severance benefits payable under this Agreement are intended to comply with the “short-term deferral exception” under Treas. Reg. §1.409A-1(b)(4), and
any remaining amount is intended to comply with the “separation pay exception” under Treas. Reg. §1.409A-1(b)(9)(iii); provided, however, any amount payable to Employee during the six (6) month period following Employee’s
last day of employment with the Company that does not qualify within this exception and constitutes deferred compensation subject to the requirements of Section 409A shall hereinafter be referred to as the “Excess Amount.” If at the
time of Employee’s separation from service, the Company’s (or any entity required to be aggregated with the Company under Section 409A) stock is publicly-traded on an established securities market or otherwise and Employee is a
“specified employee” (as defined in Section 409A and determined in the sole discretion of the Company (or any successor thereto) in accordance with the Company’s (or any successor thereto) “specified employee”
determination policy), then the Company shall postpone the commencement of the payment of the portion of the Excess Amount that is payable within the six (6) month period following Employee’s last day of employment with the Company (or any
successor thereto) for six (6) months following Employee’s last day of employment with the Company (or any successor thereto). The delayed Excess Amount shall be paid in a lump sum to Employee within thirty (30) days following the
date that is six (6) months following Employee’s last day of employment with the Company (or any successor thereto) and any amounts payable after such six (6) month period shall be paid in accordance with its original schedule. If
Employee dies during such six (6) month period and prior to the payment of the portion of the Excess Amount that is required to be delayed on account of Section 409A, such Excess Amount shall be paid to the personal representative of
Employee’s estate within sixty (60) days after Employee’s death. 
 (c) Reimbursements. All reimbursements provided
under this Agreement shall be made or provided in accordance with the requirements of Section 409A, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during Employee’s lifetime (or during
a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of
an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is incurred, and (iv) the right to reimbursement is not subject to liquidation or exchange for another benefit. 

5. Certain Representations and Warranties of Employee. Employee represents and warrants that Employee is entering into this Agreement
voluntarily and that Employee’s employment hereunder and compliance with the terms and conditions of this Agreement will not conflict with, or result in a breach of, any agreement to which Employee is a party or by which Employee may be bound,
or any legal duty that Employee owes or may owe to another. 
 6. Restrictive Covenants. As a material condition of the Company’s
offer of employment to Employee, Employee is obligated to execute and adhere to the Company’s Employee Work Product, Confidentiality, Non-Competition, and
Non-Solicitation Agreement, a copy of which is appended hereto as Exhibit A and the terms of which are hereby fully incorporated herein by reference. 

  
 4 

 7. Notices. For the purposes of this Agreement, any notice or demand hereunder to or
upon any party hereto required or permitted to be given or made shall be deemed to have been duly given or made for all purposes if (a) in writing and sent by (i) messenger or an overnight courier service, or (ii) certified or
registered mail, postage paid, return receipt requested, or (b) sent by telefax, telex, an attachment to an electronic mail message in “pdf” or similar format, or similar electronic means, to such party at the following address: 

In the case of Employee, to Employee at the last known address of Employee contained in the personnel records of the Company. 

In the case of the Company, to it at: 

WCG Clinical, Inc. 
 212
Carnegie Center, Suite 301 
 Princeton, NJ 08540 

Attention: Chief Legal Officer 

Emai: bshander@wcgclinical.com 
 or, in the case
of either party, as applicable, to such other names or addresses as the Company or Employee, as the case may be, shall designate by notice to each other person entitled to receive notices in the manner specified in this Section. 

8. Severability; Assignment. 
 (a)
If any portion of this Agreement is held invalid or unenforceable by a court of competent jurisdiction, such portion shall be deemed deleted as though it had never been included herein, but the remainder of this Agreement shall remain in full force
and effect. 
 (b) This Agreement (i) shall not be assignable by Employee without the prior written consent of the Company except
pursuant to the laws of descent and distribution and then only for purposes of enforcing Employee’s rights under Sections 2(e), 2(f) and 4 and (ii) shall be assignable by the Company only with the consent of Employee, which consent
shall not be unreasonably withheld, conditioned or delayed; provided, however, that the Company may assign its rights and obligations under this Agreement without consent of Employee in the event that the Company shall effect a
reorganization or consolidate or merge with, sell all or substantially all of its equity or assets to, or enter into any other transaction with, any other entity. 

9. Cooperation With Regard to Litigation; Waiver of Trial By Jury. 

(a) Employee agrees to cooperate with the Company during the term of this Agreement and thereafter (including following Employee’s
termination of employment for any reason) by making himself or herself reasonably available to testify on behalf of the Company or its affiliates, in any action, suit or proceeding, whether civil, criminal, administrative, or investigative, and to
assist the Company or any of its affiliates in any such action, suit, or proceeding by providing information and meeting and consulting with its counsel and representatives. Employee shall be fully reimbursed for any
out-of-pocket expenses reasonably incurred by Employee in the course of such cooperation. 

(b) Each of the parties to this Agreement irrevocably and unconditionally waives the right to a trial by jury in any action, suit or
proceeding arising out of, connected with or relating to this Agreement, the matters contemplated hereby, or the actions of the parties in the negotiation, administration, performance or enforcement of this Agreement. 

  
 5 

 10. No Debarment. Employee represents, warrants and covenants that she (i) has not
been convicted of a crime within the past ten (10) years; (b) is not currently, nor has ever been, debarred, excluded, suspended, and/or declared ineligible by the U.S. Department of Health and Human Services, U.S. Food and Drug Administration,
or any other state or federal agency from receiving federal or state money or contracts; and (iii) is not subject to, nor is there any U.S. Department of Health and Human Services, U.S. Food and Drug Administration, or any other state or
federal agency action or investigation relating to debarment, exclusion, suspension, and/or a declaration of ineligibility from receiving federal or state money or contracts currently pending or threatened against Employee. Employee covenants to
immediately report to the Company any change in status with respect to the foregoing statements that arise during employment. 
 11. No
Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict
adherence to that term or any other term of this Agreement. 
 12. Successors; Binding Agreement. This Agreement shall inure to the
benefit of and be binding upon the Company, its successors and permitted assigns. This Agreement shall also inure to the benefit of and be binding upon Employee, Employee’s executors, administrators and heirs. 

13. Governing Law. This Agreement shall be governed by and construed in accordance with, the laws of the State of New Jersey without
regard to conflict or choice of law provisions or rules that would defer to the substantive laws of another jurisdiction. Any suit or proceeding arising from the subject matter of this Agreement shall only be brought in the state or federal courts
located in Mercer County in the State of New Jersey. The Parties agree that such venue is appropriate and Employee waives any and all rights to contest the exclusive personal jurisdiction and venue of such courts. 

14. No Third Party Beneficiaries. Nothing contained in this Agreement, whether express or implied, is intended, or shall be deemed, to
create or confer any right, interest or remedy for the benefit of any person other than as otherwise provided in this Agreement. 
 15.
Insurance and Indemnity. The Company shall, to the fullest extent permitted by applicable law and solely in accordance with the terms of the Company’s bylaws as in effect at any time, indemnify Employee for any liabilities by
reason of the fact that such person is or was a director or officer of the Company. The Company shall also provide Employee with any coverage under any directors and officers liability insurance policy which is at any time maintained for the benefit
of the Company’s directors and officers. 
 16. Entire Agreement. This Agreement and any Separation Release executed pursuant to
Section 2(b) of this Agreement supersede all prior employment or other agreements, negotiations or understandings of any kind with respect to the subject matter hereof and contain the entire understanding between the parties hereto with respect
to the subject matter hereof, including without limitation that previous employment agreement between Employee and the Company dated as of July 27, 2012 and the Original Agreement. Any representation, premise or condition, whether written or
oral, not specifically incorporated herein, shall have no binding effect upon the parties. 
 17. Headings. The headings contained in
this Agreement are included for convenience and reference purposes only and shall be given no effect in the construction or interpretation of this Agreement. 

18. Amendments. No modification, termination or waiver of any provision of this Agreement shall be valid unless it is in writing and
signed by the party against whom the same is sought to be enforced. 

  
 6 

 19. Survival. To the extent consistent with their terms, the covenants in Sections
2, 3, 6, 7, 9, 10, 11 12 and 13 hereof shall survive the termination or expiration of this Agreement and the termination of Employee’s employment hereunder. 

20. Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. 
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed as of the date first above written. 
  

			
	WCG Clinical, Inc.
		
	By:	 	 /s/ Lisa Calicchio

		
	Name:	 	Lisa Calicchio
		
	Title:	 	 Chief Human Capital Management Officer

		
	By:	 	 /s/ Laurie Jackson

		
	Name:	 	Laurie Jackson

  
 7 

 Exhibit A 

Restrictive Covenant Agreement 

See Attached 

  
 8 

			
	

	  	

  

 (WCG Standard) 

EMPLOYEE CONFIDENTIALITY, WORK PRODUCT, 

NON-COMPETITION, AND NON-SOLICITATION AGREEMENT 

This Employee Work Product, Confidentiality, Non-Competition, and
Non-Solicitation Agreement (the “Agreement”) is made and entered by and between Laurie Jackson (the “Employee”) and WCG Clinical, Inc., on behalf of itself, its parents,
affiliates, subsidiaries, divisions, related companies or entities, and its and their respective members, predecessors, successors, and assigns (collectively, the “Company”). 

The Company is engaged in the highly competitive clinical research industry and offers leading regulatory, technical, compliance, quality, and
ethical review services and processes. Employee’s role with the Company involves a position of trust and confidence in which Employee will have access to Confidential Information (defined in Section 2.1 below), and Employee’s
activities will directly or indirectly support the Company’s business, research and development efforts, business and customer relationships, reputation, and goodwill, all of which are the result of significant investments and are valuable
interests, and which, if used or diverted to benefit a competitor, would cause irreparable harm. To protect these interests and investments and for good and valuable consideration, including, without limitation, Employee’s at-will employment or any changes to that employment (including position or compensation changes), access to professional advancement potential, including specialized training and enhanced compensation
opportunities, access to Confidential Information, and opportunity to develop, maintain, or enhance business and customer relationships, Employee agrees to the following: 

1. DISCLOSURE AND ASSIGNMENT OF WORK PRODUCT. 

1.1. Disclosure of Company Work Product. Employee will disclose promptly in writing to the Company all Company Work
Product. “Company Work Product” means: (a) all ideas, concepts, information, materials, programs, know-how, improvements, discoveries, research, developments, designs, data, reports, plans,
systems, technologies, products, techniques, methods, and processes, whether or not patentable, and all Confidential Information, trademarks, service marks, trade dress, design marks, design rights, logos, domain names, handles, user names, trade
names, mask work rights, patents, and other intellectual property rights, title, or interest (including, but not limited to, all related patent applications and all priority rights) recognized by the laws of any jurisdiction or country whether or
not registered, which were: (i) conceived, created and/or reduced to practice by Employee, either solely or jointly with others, during Employee’s employment with the Company (whether or not during Employee’s hours of work, and
whether or not with the use the Company’s facilities, materials, or personnel) and for a period of twelve (12) months following the termination of Employee’s employment from the Company, and (ii) related to the actual or
anticipated business or activities of the Company, and/or suggested by or resulting from any task assigned by or to Employee or work performed by Employee for, or on behalf of, the Company; and (b) all copyrightable works (including, without
limitation, writings, presentations, reports, programs, drawings, tables, graphs, images, and recordings) Employee creates or prepares during and within the scope of Employee’s employment within the Company or relating to work performed for the
Company, whether or not created or prepared during Employee’s hours of work or with the use of the Company’s facilities, materials, or personnel, and regardless of whether the Company specifically requested the preparation of such work.

  
 Employee’s
Initials:                     
 WCG
Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 1.2. Ownership of Company Work Product. All Company Work Product is the
sole and exclusive property of the Company and considered work made for hire, and the Company will retain worldwide rights thereto. To the extent that any Company Work Product is not considered work made for hire, Employee agrees to assign and
hereby assigns all rights, title, and interests in Company Work Product to the Company. Employee agrees that all Prior Work Product made or acquired by Employee prior to employment with the Company has been identified on a fully
executed copy of Schedule A. Employee also agrees not to assert rights to any Company Work Product that has not been identified as Prior Work Product on Schedule A. During the period of Employee’s employment and thereafter, Employee and
Employee’s assigns, executors, administrators, and representatives will execute any applications, assignments, or other instruments that the Company considers necessary to apply for, obtain, transfer, or maintain a patent, trademark or
copyright registration, or other proprietary or intellectual property rights to protect the interests of the Company with respect to Company Work Product. Employee will not incorporate, or permit to be incorporated, any Prior Work Product into any
Company process, procedure, technique, equipment, property, or Company Work Product without the Company’s prior written consent. 
 2. CONFIDENTIAL
INFORMATION AND COMPANY PROPERTY. 
 2.1. Confidential Information. “Confidential Information”
means all information relating to the Company and/or its operations that is not generally available to the public, including, without limitation, information related to the Company’s business and operating plans or strategies, trade secrets,
potential or pending acquisitions, financial information, market analyses, personnel, contractors, vendors or service providers, compensation received or provided, know-how, customer and supplier lists and
relationships, product plans, research and development activities, inventions, processes, methodologies, techniques, specifications, algorithms, formulas, technologies, hardware configurations, software and software development, engineering,
testing, Company Work Product, all non-public proprietary, confidential, or trade secret information in oral, written, electronic, or other form, and any non-public
information the Company has received or will receive from third parties which is entitled to confidentiality or use only for limited purposes. 

2.2. Confidentiality and Return of Confidential Information and Company Property. During and after Employee’s
employment with the Company, Employee (i) will hold in confidence and will not disclose or use any Confidential Information except as required and authorized in the scope of Employee’s employment with the Company; and (ii) will not
exceed Employee’s Company-authorized access to any internal or external Company network. The restrictions on the use or disclosure of Confidential Information shall not apply to information that is or has become, prior to the use or disclosure,
generally known by the public other than as the direct or indirect result of a breach of this Agreement by Employee, or to information that is required to be disclosed by law or judicial or administrative process. Employee must provide the Company
with immediate, prior notice in writing (if permitted by law) identifying the terms and circumstances surrounding any required disclosure of Confidential Information so the Company may seek an appropriate order or other remedy. 

  
 2 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 Upon termination of Employee’s employment with the Company, and/or upon the
Company’s request, Employee will: (i) deliver to the Company all of the Company’s property, electronic devices, equipment, and documents, together with all copies thereof, and any other material containing or disclosing Confidential
Information, and (ii) certify in writing that Employee has fully complied with the foregoing obligation. Employee will not make or retain copies of Confidential Information in any form whatsoever (including, without limitation, information
contained in computer memory or stored on electronic devices, including hard drives and removable storage media, and information in online or cloud storage or backup or restoration points). Employee will not delete or alter any information contained
on any Company computer or other electronic device or equipment before returning the Company computer or other electronic device or equipment to the Company. 

For the avoidance of doubt, notwithstanding any provisions in this Agreement or Company policy applicable to the unauthorized use or
disclosure of Confidential Information, Employee is hereby notified that, pursuant to the Defend Trade Secrets Act as contained in 18 U.S.C. § 1833, Employee cannot be held criminally or civilly liable under any Federal or State trade secret
law for the disclosure of a trade secret that is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a
suspected violation of law. Employee also may not be held so liable for such disclosures made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, individuals who file a
lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document
containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order provided the Employee’s actions are consistent with 18 U.S.C. § 1833. 

3. RESTRICTIVE COVENANTS AND FUTURE EMPLOYMENT. 

3.1. Definitions.  

3.1.1. “Business” means all clinical, technical, regulatory, compliance, quality, and ethical review products,
technologies, processes, data applications, platforms, and databases designed for, developed for, used in, or marketed to the clinical research industry, including the management and service thereof. 

3.1.2. “Competitor” means any person or entity that is currently engaged, preparing be engaged, or intending to engage
in Business or any product, process, technology, machine, invention, or service that competes with, or is intended to compete with, any product, process, technology, machine, invention, or service the Company offers or is developing. 

  
 3 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 3.2. Non-Competition. During
Employee’s employment within the Company and for a period of twenty-four (24) months following the termination of Employee’s employment with the Company, Employee shall not directly or indirectly (on Employee’s own or in
combination or association with others, and whether for Employee’s own benefit or for the benefit of other persons or entities) perform, or assist others to perform, work for a Competitor in the same geographic area in which the Employee
performed work for the Company, in the form of Business that Employee provided the Company (whether the Company engaged or was preparing to engage in such Business), and in any Business about which Employee learned Confidential Information during
Employee’s employment with the Company. Employee agrees that the foregoing geographic and temporal scope is reasonable and appropriate based on the nature of the Company’s Business and Employee’s involvement therewith. This Agreement
does not restrict or impede, in any way, and shall not be interpreted or understood as restricting or impeding, Employee from discussing the terms and conditions of the Employee’s employment or exercising protected rights that cannot be waived
by agreement, including under the National Labor Relations Act. 
 3.3. Non-Solicitation
of Customers. During Employee’s employment with the Company and for a period of twenty-four (24) months following the termination of Employee’s employment with the Company, Employee shall not directly or indirectly (on
Employee’s own or in combination or association with others, and whether for Employee’s own benefit or for the benefit of other persons or entities) contact, call upon, solicit, or otherwise accept business from, render services to, market
services or products to, divert business from, and/or interfere with the Company’s relationship or business with any of the Company’s existing or prospective customers that Employee interacted with on behalf of the Company, was introduced
to by virtue of Employee’s employment with the Company, or otherwise learned Confidential Information concerning, during the last twenty-four (24) months of Employee’s employment with the Company. 

3.4. Non-Solicitation of Employees, Consultants, and Contractors. During
Employee’s employment within the Company and for a period of twenty-four (24) months following the termination of Employee’s employment with the Company, Employee shall not directly or indirectly (on Employee’s own or in
combination or association with others, and whether for Employee’s own benefit or for the benefit of other persons or entities) call upon, solicit, or otherwise engage in activity that could result in the actual or potential termination of the
Company’s relationship with any person or entity who is an employee, consultant, or independent contractor of the Company. 
 3.5.
Notifications Regarding Future Employment. Employee will notify all potential future employers of the existence and provisions of this Agreement prior to Employee beginning employment with such future employer. In the event
Employee voluntarily terminates employment with the Company, Employee will notify the Company in writing at least ten (10) calendar days before Employee’s anticipated last date of employment within the Company and of the commencement of
employment with a new employer. During the twelve (12) month period of time following the termination of Employee’s 

  
 4 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 
employment from the Company, Employee also will provide the Company with ten (10) calendar days’ written notice prior to commencing employment with a new employer and/or in a new
position. The Company may require, and the Employee agrees to provide, written assurances that contain sufficient detail to allow for an informed decision by the Company as to whether Employee’s new position of employment complies with
Employee’s obligations under this Agreement. Employee consents to the Company’s notification of Employee’s new employer of the terms contained in this Agreement. Employee will also attend an exit interview during which Employee agrees
to provide all information requested by the Company in order to comply with this Agreement. 
 3.6. Non-Disparagement. During and after the term of Employee’s employment with the Company, Employee shall not defame or disparage the Company, its officers, directors, employees, customers and business
partners including, without limitation, through statements made by Employee or at Employee’s direction, with Employee’s knowledge or involvement, in Employee’s name, anonymously, under a pseudonym, or on Employee’s behalf. 

4. BREACH OF THE AGREEMENT AND REMEDIES. 

Employee acknowledges that the covenants contained in this Agreement are reasonable and necessary to protect the legitimate interests of the
Company. Employee agrees and acknowledges that Employee’s breach of the covenants contained in this Agreement will cause irreparable harm to the Company and that damages arising out of a breach may be difficult to determine. Employee therefore
agrees and acknowledges that, in addition to all other remedies provided at law and/or in equity, the Company shall be entitled to specific performance and temporary and/or permanent injunctive relief in a court of competent jurisdiction restraining
the breach and/or further breach of this Agreement by Employee, Employee’s future employer(s), and/or others acting in concert with Employee, without the necessity of proving actual damages or posting a bond. Any period of restriction in this
Agreement shall be extended in the event of a breach, and a court of competent jurisdiction shall have the power to enforce any period of restriction in this Agreement from the date of the last breach up to a maximum of thirty-six (36) months. In addition, if the Company prevails in any suit under this Agreement, in whole or in part, then Employee shall also be liable for the Company’s costs and attorney’s fees in
connection with the lawsuit and any related legal proceedings. Should any covenant contained in this Agreement, inclusive of the alternative covenants in Paragraph 5.9, ever be adjudicated to exceed the time, geographic, product or service, or other
limitations permitted by applicable law, then a court of competent jurisdiction is expressly empowered to reform such covenant, and such covenant shall be reformed, to the maximum time, geographic, product or service, or other limitations permitted
by applicable law. The invalidity or unenforceability of any such covenant or provision as written shall not invalidate or render unenforceable the remaining covenants or provisions, and any such invalidity or unenforceability shall not invalidate
or render unenforceable such covenant or provision in any other jurisdiction. 

  
 5 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 5. GENERAL PROVISIONS. 

5.1. Survival and Third Party Beneficiaries. The Company may transfer, convey, or assign this Agreement and any rights or
obligations, in whole or in part, to any existing or future affiliate, successor, or assign of the Company or to any third party, including in connection with a merger, sale of assets, sale of stock, or any other form of acquisition or transaction
pertaining to all or part of the business of the Company, and Employee consents to such transfers, conveyances, or assignments. This Agreement shall inure to the benefit of and may be enforced by the Company and any existing or future affiliates,
successors, and assigns, and shall be binding upon Employee, Employee’s executors, administrators, legatees, and other successors in interest. This Agreement is personal to Employee’s employment within the Company and may not be assigned
by Employee for any reason. Employee further agrees that the existence or potential existence of any claim or cause of action of Employee against the Company of whatever nature shall not constitute a defense to the Company’s enforcement of
Employee’s covenants and obligations in this Agreement. 
 5.2. Entire Agreement. No modification of or amendment
to this Agreement will be effective unless in writing and signed by Employee and an authorized Company representative. Employee has not relied on any oral, written, or other representation by any Company representative concerning the subject matter
of this Agreement that is not expressly stated herein and that the terms of this Agreement, including its incorporated Schedule, are fully stated herein. This Agreement applies to Employee’s current position within the Company and to any
position which Employee may hold by promotion, transfer, or assignment, and any subsequent change in Employee’s role, responsibilities, salary, compensation, or benefits will not affect the validity, scope, or enforceability of this Agreement
or the Company’s rights and remedies in the event of a breach of this Agreement. Any previous non-competition, non-solicitation, confidentiality, non-disclosure, and/or intellectual property agreements between Employee and the Company shall remain in effect to the extent applicable therein, provided that this Agreement shall govern in the event of a conflict
of any term in any such agreement(s) and this Agreement. Should this Agreement be declared invalid, void, overbroad, or unenforceable, in whole or in part, for any reason, any previous agreement between Employee and the Company may be enforced in
whole or in part. 
 5.3. At-Will Employment. Nothing contained in this
Agreement shall be deemed to confer on Employee any rights with respect to the duration of Employee’s employment with the Company or to require advance notice by the Company prior to the termination of employment. Employee’s employment is
terminable at will by either Employee or the Company, with or without cause, except that if Employee initiates the termination, there shall be, at the Company’s option, a period of up to ten (10) calendar days after Employee gives written
notice of termination before the termination becomes effective, during which time Employee will provide such transitional services as the Company may request and the Company will continue Employee’s pay so long as Employee satisfactorily
provides such services. 

  
 6 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 5.4. No Expectation of Privacy. Employee understands that the Company
maintains an electronic mail system and other communications systems (including messaging services, phones, etc.) that Employee may use solely for the purpose of Company business and that the Company retains the right to review any and all
communications and information stored in any electronic mail system or other communication system, with or without notice, at any time, including, but not limited to, with respect to enforcing or monitoring compliance with this Agreement. 

5.5. Compliance With Obligations to Prior Employers and Other Third Parties. Employee represents and warrants that, at the
time of executing this Agreement, Employee is not subject to any prohibitions, restrictions, covenants, or commitments pursuant to any oral or written agreement that would either directly or indirectly interfere with Employee’s ability to enter
into and comply with this Agreement or to perform any duties or responsibilities of Employee’s position with the Company. During Employee’s employment within the Company, Employee will not (i) improperly use or disclose any
confidential information or trade secrets of any former employer or third party; or (ii) use any former employer or third party’s confidential information or property without such entity’s written consent while employed by the
Company. 
 5.6. Waiver. Any waiver or failure to enforce a provision of this Agreement will not be deemed to waive any
provision(s) of this Agreement in the future. 
 5.7. Notices. Each party must deliver all notices or other
communications required or permitted under this Agreement in writing to the other party at the address set forth in the Company’s records, by hand delivery or mail service with proof of delivery (i.e. courier, certified or registered mail
(return receipt requested), or express mail service). Notice will be effective upon delivery. Each party may change its address for receipt of notice by giving notice of such change to the other party. 

5.8. Governing Law and Jurisdiction. This Agreement shall be governed by and construed in accordance with laws of the
State of Delaware, without regard to its principles of conflicts of law. Any suit, action, or other proceeding arising out of this Agreement shall be subject to the exclusive jurisdiction of the federal or state courts located in the city of
Wilmington, Delaware. Employee expressly consents to the exclusive personal jurisdiction of the state and federal courts located in Wilmington, Delaware for any lawsuit filed against Employee by the Company or by Employee against the Company arising
from or related to this Agreement. Should a court refuse to enforce the parties’ agreement for Delaware choice of law pursuant to this Paragraph, then alternative covenants and provisions of Paragraph 5.9 shall apply. 

5.9. Alternative Covenants and Provisions For Employees in Certain States if Governing Law Provision is Not Enforced. 

5.9.1. For a California Employee: The restrictions in Section 3.2 shall not apply. The restrictions in Section 3.4 shall be
limited to a period of 12 months following Employee’s termination of employment with the Company, and during that time Employee agrees and covenants not to disrupt or interfere with the business of the Company by directly or indirectly
soliciting, recruiting, attempting to recruit, or raiding the employees, consultants, or contractors of the Company of whom Employee became aware by working for the Company or otherwise inducing the termination of employment of any such individual;
Employee also agrees and covenants not to use any of the Company’s trade secrets and/or 

  
 7 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 
Confidential Information to directly or indirectly solicit the employees, consultants, or contractors of the Company. The restrictions in Section 3.3 shall be limited to situations where
Employee is aided in his or her conduct by the use or disclosure of the trade secrets (as defined by applicable law) of the Company. The choice of law and choice of venue provisions in Section 5.8 shall not apply. Pursuant to California Labor
Code Section 2870, Section 1.2 will not apply to Company Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that was developed entirely on Employee’s own time, unless:
(a) the Company Work Product relates at the time of conception or reduction to practice to either: (i) the business of the Company, or (ii) the Company’s actual or demonstrably anticipated research or development; or (b) the
Company Work Product results from any work performed by Employee for the Company. 
 5.9.2. For a Delaware, Kansas, or Minnesota
Employee: Section 1.2 does not apply to Company Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that was developed entirely on Employee’s own time, unless: (a) the
Company Work Product relates at the time of conception or reduction to practice to either: (i) the business of the Company or (ii) the Company’s actual or demonstrably anticipated research or development; or (b) the Company Work
Product results from any work performed by Employee for the Company. 
 5.9.3. For an Illinois Employee: The restrictions in
Section 3.2 will not apply for so long as Employee is subject to Illinois law unless the Employee’s actual or expected annualized rate of earnings exceeds $75,0000 per year. This amount shall increase to $5,000 every five (5) years
thought January 1, 2037, at which point the amount will be $90,000 per year thereafter. In addition, If Employee resides in Illinois and is subject to Illinois law, then the restrictions in Paragraph 3.3 and 3.4 will not apply for so long as
Employee is subject to Illinois law unless the Employee’s actual or expected annualized rate of earnings exceeds $45,0000 per year. The restrictions in paragraphs 3.2 through 3.4 will not apply to an Employee for so long as Employee is subject
to Illinois law and the Employees employment was terminated, furloughed, or laid-off related to business circumstances or governmental orders related to the COVID-19
pandemic or similar circumstances, unless, enforcement of the covenants include compensation equivalent to the employee’s base salary at the time of termination for the period of enforcement minus compensation earned through subsequent
employment during the period of enforcement. This amount shall increase to $2,500 every five (5) years through January 1, 2037, at which point the amount will be $52,500 per year thereafter. For any Illinois Employee, if 765 ILCS 1060/1-3 applies, Section 1.2 does not apply to Company Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that was developed entirely on
Employee’s own time, unless: (a) the Company Work Product relates at the time of conception or reduction to practice to either: (i) the business of the Company or (ii) the Company’s actual or demonstrably anticipated
research or development; or (b) the Company Work Product results from any work performed by Employee for the Company. 
 5.9.4.
For a Massachusetts Employee: 
  

	 	(a)	 Employee acknowledges that he/she may consult with an attorney prior to signing this Agreement. Employee
acknowledges that if he/she is being initially hired by the Company, that Employee received a copy of this Agreement prior to receiving a formal offer of employment from the Company or at least ten (10) business days before commencement of
Employee’s employment by the Company, whichever came first. If Employee was already employed by the Company at the time of signing this Agreement, that Employee was provided a copy hereof at least ten (10) business days before the
effective date of this Agreement. 

  
 8 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

	 	(b)	 The choice of venue provision in Section 5.8 shall not apply. Employee hereby expressly consents to the
exclusive personal jurisdiction of the state or federal court located in the county where Employee resides or the business litigation session of the applicable superior court in Massachusetts for any dispute arising from or related to this
Agreement. 

  

	 	(c)	 The Company will not be obligated to make any Garden Leave Payments and Section 3.2 will not apply if:
(i) the Company chooses, in its sole discretion, to waive in writing the provisions of Section 3.2 at or before the time of Employee’s termination, (ii) Employee is terminated without cause or laid off as part of a reduction in
force, or (iii) Employee is in breach of his or her obligations set forth in Section 3.2 as determined by the Company. Employee understands that for the limited purposes of the application of the
non-competition clause in Section 3.2 of the Agreement, “cause” to terminate Employee’s employment exists if Employee has (i) committed, admitted committing, or plead guilty to a
felony or crime involving moral turpitude, fraud, theft, misappropriation, or dishonesty, (ii) violated a material term of this Agreement or policy of the Company, (iii) engaged in insubordination, or failed or refused to perform assigned
duties of Employee’s position (other than due to physical or mental illness) despite reasonable opportunity to perform, (iv) failed to exercise reasonable care and diligence in the exercise of Employee’s duties for the Company, or
(iv) engaged in conduct or omissions that Employee knew, or should have known (with the exercise of reasonable care), would cause, or be likely to cause, harm to the Company or its reputation in the business community. If Employee breaches
Section 3.2 of this Agreement, and also breaches Employee’s fiduciary duty to the Company and/or has unlawfully taken, physically or electronically, any Confidential Information, then the period specified in Section 3.2 shall be
extended to a period of twenty-four (24) months from the termination of Employee’s employment. 

  

	 	(d)	 Section 3.2 shall not apply to Employee post-employment if Employee is: (i) classified as non-exempt under the Fair Labor Standards Act; (ii) 18 years or younger; or (iii) an undergraduate or graduate student in an internship or other short-term employment relationship while enrolled in college or
graduate school. 

  
 9 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

	 	(e)	 If Section 3.2 remains effective after the termination of Employee’s employment, and the Company
provides Garden Leave Payments, Employee shall receive on a pro-rata basis fifty (50) percent of Employee’s highest annualized base salary paid by the Company within the twenty-four (24) months
preceding the termination of Employee’s employment with the Company (“Garden Leave Payments”). Garden Leave Payments, less all legally required and voluntarily authorized deductions, shall be paid consistent with how Employee was paid
during his or her employment, for the duration of the twelve (12) month period of restriction under Section 3.2 so long as Employee is in compliance with his or her obligations thereunder. Under no circumstances will Garden Leave Payments
be made beyond this twelve (12) month period if the duration of Section 3.2 is extended beyond twelve (12) months for breaching Employee’s fiduciary duty to the Company and/or for unlawfully taking, physically or electronically,
property or Confidential Information belonging to the Company. If Employee breaches Section 3.2, in addition to seeking relief as set forth in Section 4, the Company may discontinue Garden Leave Payments. 

5.9.5. For a New York Employee: The restriction in Section 3.3 is modified to exclude those customers who became a customer of the
Company as a result of Employee’s independent contact and business development efforts with the customer prior to and independent from his/her employment with the Company. 

5.9.6. For a Nevada employee: If Employee resides in Nevada and is subject to Nevada law, then the following applies to Employee for so
long as Employee is subject to Nevada law: Paragraph 3 does not preclude Employee from providing services to any former client or customer of Employer if: (a) Employee did not solicit the former customer or client; (b) the customer or
client voluntarily chose to leave and seek services from Employee; and (c) Employee is otherwise complying with the limitations in this Agreement as to time and scope of activity to be restrained. However, Paragraph 3.2 may not apply to an
employee who is paid solely on an hourly wage basis, exclusive of any tips or gratuities. 
 5.9.7. For a North Carolina Employee:
Employee’s non-disclosure obligation in Section 2.2 shall extend for a period of three (3) years after Employee’s termination as to Confidential Information that does not qualify for
protection as a trade secret. Trade secret information shall be protected from disclosure as long as the information at issue continues to qualify as a trade secret; and (b) the applicable period of time shall be calculated by looking back two
years from the date of enforcement and not from the date employment ends. In addition, Section 1.2 does not apply to Company Work Product for which no equipment, supplies, facility, or trade secret information of the Company was used and that
was developed entirely on Employee’s own time, unless: (a) the Company Work Product relates at the time of conception or reduction to practice to either: (i) the business of the Company or (ii) the Company’s actual or
demonstrably anticipated research or development; or (b) the Company Work Product results from any work performed by Employee for the Company. 

  
 10 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 5.9.8. For an Oregon Employee: If Employee resides in Oregon and is subject to Oregon
law, then the following applies to Employee for so long as Employee is subject to Oregon law: the restrictions in Paragraph 3 shall only apply if Employee: (a) is engaged in administrative, executive or professional work and performs
predominantly intellectual, managerial, or creative tasks, exercises discretion and independent judgment and earns a salary or is otherwise exempt from Oregon’s minimum wage and overtime laws; (b) the Company has a “protectable
interest” (meaning, access to trade secrets or competitively sensitive confidential business or professional information); and (c) the total amount of the Employee’s annual gross salary and commission, calculated on an annual basis,
at the time of the Employee’s termination, exceeds $100,533, adjusted annually for inflation pursuant to the Consumer Price Index for All Urban Consumers, West Region (All Items), as published by the Bureau of Labor Statistics of the United
States Department of Labor immediately preceding the calendar year of the employee’s termination. However, if Employee does not meet requirements of either (a) or (c) (or both), the Company may, on a case-by-case basis, decide to make Paragraph 3 enforceable as to Employee (as allowed by Oregon law), but paying the Employee during the period of time the Employee is restrained from competing the greater of
compensation equal to at least: (i) Fifty percent of the employee’s annual gross base salary and commissions at the time of the employee’s termination; or (ii) Fifty percent of $100,533, adjusted annually for inflation pursuant
to the Consumer Price Index for All Urban Consumers, West Region (All Items), as published by the Bureau of Labor Statistics of the United States Department of Labor immediately preceding the calendar year of the employee’s termination. 

5.9.9. For a Washington Employee: 
  

	 	(a)	 Employee acknowledges that if Employee is a new employee, Employee has had advance notice of the terms
of this Agreement prior to accepting the Company’s offer of employment. 

  

	 	(b)	 Section 3.2 will not apply to Employee after termination of employment with the Company if
Employee’s annualized earnings from the Company did not exceed $100,000.00 per year (adjusted in accordance with Section 5 of Washington HP 1450). 

  

	 	(c)	 Section 3.2 will not apply to Employee during employment if Employee earns less than twice the
Washington minimum hourly wage (subject to the common law duty of loyalty and Company policies). 

  
 11 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

	 	(d)	 Employee also understands that the non-competition provision in
Section 3.2 will not be enforced against Employee if Employee is terminated from employment without cause or if Employee is laid off unless the Company pays Employee during the 12-month non-competition period an amount equal to the Employee’s base salary at the time of termination minus any compensation earned by Employee during the 12-month non-competition period. Employee further understands that for the limited purposes of the application of the non-competition provision in Section 3.2 of the Agreement,
“cause” to terminate Employee’s employment exists if Employee has: (i) committed, admitted committing, or plead guilty to a felony or crime involving moral turpitude, fraud, theft, misappropriation, or dishonesty,
(ii) violated a material term of this Agreement or policy of the Company, (iii) engaged in insubordination, or failed or refused to perform assigned duties of Employee’s position despite reasonable opportunity to perform,
(iv) failed to exercise reasonable care and diligence in the exercise of Employee’s duties for the Company, or (iv) engaged in conduct or omissions that Employee knew, or should have known (with the exercise of reasonable care), would
cause, or be likely to cause, harm to the Company or its reputation in the business community. 

  

	 	(e)	 Section 1.2 does not apply to Company Work Product for which no equipment, supplies, facility, or
trade secret information of the Company was used and that was developed entirely on Employee’s own time, unless: (a) the Company Work Product relates at the time of conception or reduction to practice to either: (i) the business of
the Company or (ii) the Company’s actual or demonstrably anticipated research or development; or (b) the Company Work Product results from any work performed by Employee for the Company. 

5.9.10. For a Virginia Employee: A low-wage Employee shall not be subject to the restrictions
identified in Section 3.2. A low-wage Employee shall only be restricted from providing services prohibited by Section 3.3 if Employee initiated contact or solicited such services. “Low
wage” employees include: (i) those whose average annual earnings are less than $62,608 (adjusted periodically by Va. Code Ann. § 65.2-500(B)); (ii) interns, students, apprentices, or trainees
employed, with or without pay, at a trade or occupation in order to gain work or education experience; and (iii) independent contractors who are compensated at an hourly rate that is less than the median hourly wage for occupations as set by
the U.S. Bureau of Labor Statistics. “Low wage” employees do not include employees who derive earnings, in whole or in predominant part, from sales commissions, incentives, or bonuses from the Company. 

5.9.11. For a Wisconsin Employee: Employee’s nondisclosure obligation in Section 2.2 shall extend for a period of three
(3) years after Employee’s termination as to Confidential Information that does not qualify for protection as a trade secret. Trade secret information shall be protected from disclosure as long as the information at issue continues to
qualify as a trade secret. Section 3.4 is rewritten to read as follows: “While employed and for a period of one (1) year from the date of the termination of Employee’s employment with the Company, Employee will not participate in
soliciting any Covered Employee of the Company that is in a Sensitive Position to leave the employment of the Company on behalf of (or for the benefit of) a Competing Business. As used in this paragraph, an employee is a ‘Covered Employee’
if the employee is someone with whom Employee worked, as to whom Employee had supervisory responsibilities, or regarding which Employee received Confidential Information during the 

  
 12 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 
last twenty-four (24) months of Employee’s employment with the Company. An employee in a ‘Sensitive Position’ refers to an employee of the Company who is in a management,
supervisory, sales, research, and development, or similar role where the employee is provided Confidential Information or is involved in business dealings with the customers or clients of the Company.” 

5.9.12. For a Washington, DC Employee: Section 3.2 does not apply to any Employee entering this Agreement after the applicability and
effective date for DC Code §§ 32-581.01 et seq. Pursuant to that law, no employer operating in the District of Columbia may request or require any employee working in the District of Columbia to
agree to a non-compete policy or agreement, in accordance with the Ban on Non-Compete Agreements Amendment Act of 2020. Employee agrees that he/she has been provided the
foregoing notice required by the Act within 90 days of the Act’s effective date, 7 days of hire by the Company, or 14 days after Employee’s request for such notice. 

EMPLOYEE ACKNOWLEDGES HAVING RECEIVED AND READ A COPY OF THIS AGREEMENT. EMPLOYEE AGREES TO THE TERMS ABOVE AND ACKNOWLEDGES THAT EMPLOYEE INTENDS TO BE
LEGALLY BOUND BY THIS AGREEMENT. 
  

							
	WCG Clinical, Inc.	 	Employee
				
	By:	 	 /s/ Lisa Calicchio
	 	By:	 	 /s/ Laurie Jackson

	 Lisa Calicchio
 Chief Human Capital
Management Officer
 212 Carnegie Center, Suite 301
 Princeton,
NJ 08540
	 	Laurie Jackson
		
	Date: July 23, 2021	 	Date: July 23, 2021

  
 13 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021) 

			
	

	  	

  

 SCHEDULE A 

DISCLOSURE OF PRIOR WORK PRODUCT 

I agree and acknowledge that the following is a complete list of: (a) all ideas, concepts, information, materials, data, programs, know-how, improvements, discoveries, research, developments, designs, data, reports, plans, systems, technologies, products, techniques, methods, and processes, whether or not patentable, and all confidential
information and trade secrets, trademarks, service marks, trade dress, design marks, design rights, logos, domain names, handles, user names, trade names, mask work rights, patents, and other intellectual property rights, title, or interest
(including, but not limited to, all related patent applications and all priority rights) recognized by the laws of any jurisdiction or country whether or not registered that Employee created or prepared prior to Employee’s employment with the
Company; and (b) all copyrightable works (including writings, presentations, reports, computer programs, drawings, tables, graphs, images, and recordings) that Employee created or prepared prior to Employee’s employment with the Company
(the “Prior Work Product”): 
  

	 	☒	 None 

  

	 	☐	 See below: 

  

			
	        	  	  

		
		  	  

		
		  	  

		
		  	  

		
		  	  

 Employee 
  

			
	By:	 	 /s/ Laurie Jackson

		 	Laurie Jackson
		
	Date:	 	July 23, 2021

  
 14 

Employee’s Initials:                     

WCG Confidentiality and Non-Competition Agreement (Standard Version, July 2021)EX-10.11

 Exhibit 10.11 

 

WCG CLINICAL, INC. 

2021 INCENTIVE AWARD PLAN 

ARTICLE I. 
 PURPOSE

 The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to
make) important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI.. 

ARTICLE II. 
 ELIGIBILITY

 Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein. 

ARTICLE III. 

ADMINISTRATION AND DELEGATION 

3.1 Administration. The Plan is administered by the Administrator. The Administrator has authority to determine which Service Providers
receive Awards, grant Awards and set Award terms and conditions, subject to the conditions and limitations in the Plan. The Administrator also has the authority to take all actions and make all determinations under the Plan, to interpret the Plan
and Award Agreements and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan or any
Award as it deems necessary or appropriate to administer the Plan and any Awards. The Administrator’s determinations under the Plan are in its sole discretion and will be final and binding on all persons having or claiming any interest in the
Plan or any Award. The Administrator may institute and determine the terms and conditions of an Exchange Program. 
 3.2 Appointment of
Committees. To the extent Applicable Laws permit, the Board may delegate any or all of its powers under the Plan to one or more Committees or officers of the Company or any of its Subsidiaries. The Board may abolish any Committee or re-vest in itself any previously delegated authority at any time. 
 ARTICLE IV. 

STOCK AVAILABLE FOR AWARDS 

4.1 Number of Shares. Subject to adjustment under Article VII and the terms of this Article IV, Awards may be
made under the Plan covering up to the Overall Share Limit. Shares issued under the Plan may consist of authorized but unissued Shares, Shares purchased on the open market or treasury Shares. 

4.2 Share Recycling. If all or any part of an Award expires, lapses or is terminated, exchanged for cash, surrendered to an Exchange
Program, repurchased, canceled without having been fully exercised or forfeited, in any case, in a manner that results in the Company acquiring Shares at a price not greater than the price (as adjusted to reflect any Equity Restructuring) paid by
the Participant for such Shares or not issuing any Shares covered by the Award, the unused Shares covered by the Award will, as applicable, become or again be available for Award grants under the Plan. Further, Shares delivered (either by actual

 
delivery or attestation) to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award and/or to satisfy any applicable tax withholding obligation (including
Shares retained by the Company from the Award being exercised or purchased and/or creating the tax obligation) will, as applicable, become or again be available for Award grants under the Plan. The payment of Dividend Equivalents in cash in
conjunction with any outstanding Awards shall not count against the Overall Share Limit. 
 4.3 Incentive Stock Option Limitations.
Notwithstanding anything to the contrary herein, no more than 37,918,905 Shares may be issued pursuant to the exercise of Incentive Stock Options. 

4.4 Substitute Awards. In connection with an entity’s merger or consolidation with the Company or the Company’s acquisition of
an entity’s property or stock, the Administrator may grant Awards in substitution for any options or other stock or stock-based awards granted before such merger or consolidation by such entity or its affiliate in accordance with Applicable
Laws. Substitute Awards may be granted on such terms as the Administrator deems appropriate, notwithstanding limitations on Awards in the Plan. Substitute Awards will not count against the Overall Share Limit (nor shall Shares subject to a
Substitute Award be added to the Shares available for Awards under the Plan as provided above), except that Shares acquired by exercise of substitute Incentive Stock Options will count against the maximum number of Shares that may be issued pursuant
to the exercise of Incentive Stock Options under the Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such
pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration
payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares subject to such Awards shall not
be added to the Shares available for Awards under the Plan as provided above); provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or Directors prior to such acquisition or combination. 

4.5 Non-Employee Director Compensation. Notwithstanding any provision to the contrary in the
Plan, the Administrator may establish compensation for non-employee Directors from time to time, subject to the limitations in the Plan. The Administrator will from time to time determine the terms, conditions
and amounts of all such non-employee Director compensation in its discretion and pursuant to the exercise of its business judgment, taking into account such factors, circumstances and considerations as it
shall deem relevant from time to time, provided that the sum of any cash compensation, or other compensation, and the value (determined as of the grant date in accordance with Financial Accounting Standards Board Accounting Standards Codification
Topic 718, or any successor thereto) of Awards granted to a non-employee Director as compensation for services as a non-employee Director during any fiscal year of the
Company may not exceed $1,000,000 of a non-employee Director’s initial service as a non-employee Director. The Administrator may make exceptions to these limits for
individual non-employee Directors in extraordinary circumstances, as the Administrator may determine in its discretion, provided that the non-employee Director receiving
such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions involving non-employee Directors. 

  
 2 

 ARTICLE V. 

STOCK OPTIONS AND STOCK APPRECIATION RIGHTS 

5.1 General. The Administrator may grant Options or Stock Appreciation Rights to Service Providers subject to the limitations in the
Plan, including any limitations in the Plan that apply to Incentive Stock Options. The Administrator will determine the number of Shares covered by each Option and Stock Appreciation Right, the exercise price of each Option and Stock Appreciation
Right and the conditions and limitations applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other person entitled to exercise the Stock Appreciation Right) to receive
from the Company upon exercise of the exercisable portion of the Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of exercise over the exercise price per Share of the
Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right is exercised, subject to any limitations of the Plan or that the Administrator may impose and payable in cash, Shares valued at such Fair Market
Value or a combination of the two as the Administrator may determine or provide in the Award Agreement. 
 5.2 Exercise Price. The
Administrator will establish each Option’s and Stock Appreciation Right’s exercise price and specify the exercise price in the Award Agreement. Unless otherwise determined by the Administrator, the exercise price will not be less than 100%
of the Fair Market Value on the grant date of the Option or Stock Appreciation Right. 
 5.3 Duration. Each Option or Stock
Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that, unless otherwise determined by the Administrator in accordance with Applicable Laws, the term of an Option or Stock Appreciation Right will
not exceed ten years. Notwithstanding the foregoing, if the Participant, prior to the end of the term of an Option or Stock Appreciation Right, violates the non-competition,
non-solicitation, confidentiality or other similar restrictive covenant provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the
Company or any of its Subsidiaries, the right of the Participant and the Participant’s transferees to exercise any Option or Stock Appreciation Right issued to the Participant shall terminate immediately upon such violation unless the Company
otherwise determines. 
 5.4 Exercise. Options and Stock Appreciation Rights may be exercised by delivering to the Company a written
notice of exercise, in a form the Administrator approves (which may be electronic), signed by the person authorized to exercise the Option or Stock Appreciation Right, together with, as applicable, payment in full (i) as specified in
Section 5.5 for the number of Shares for which the Award is exercised and (ii) as specified in Section 9.5 for any applicable taxes. Unless the Administrator otherwise determines, an Option or Stock Appreciation Right may not be
exercised for a fraction of a Share. 
 5.5 Payment Upon Exercise. Subject to Section 10.8, any Company insider trading policy
(including blackout periods) and Applicable Laws, the exercise price of an Option must be paid by: 
 (a) cash, wire transfer of immediately
available funds or by check payable to the order of the Company, provided that the Company may limit the use of one of the foregoing payment forms if one or more of the payment forms below is permitted; 

(b) if there is a public market for Shares at the time of exercise, unless the Company otherwise determines, (A) delivery (including
telephonically to the extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to pay the exercise price, or (B) the
Participant’s delivery to the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to pay the exercise price; provided that such
amount is paid to the Company at such time as may be required by the Administrator; 

  
 3 

 (c) to the extent permitted by the Administrator, delivery (either by actual delivery or
attestation) of Shares owned by the Participant valued at their Fair Market Value; 
 (d) to the extent permitted by the Administrator,
surrendering Shares then issuable upon the Option’s exercise valued at their Fair Market Value on the exercise date; 
 (e) to the
extent permitted by the Administrator, delivery of any other property that the Administrator determines is good and valuable consideration; or 

(f) to the extent permitted by the Company, any combination of the above payment forms approved by the Administrator. 

ARTICLE VI. 
 RESTRICTED
STOCK; RESTRICTED STOCK UNITS 
 6.1 General. The Administrator may grant Restricted Stock, or the right to purchase Restricted
Stock, to any Service Provider, subject to the Company’s right to repurchase all or part of such shares at their issue price or other stated or formula price from the Participant (or to require forfeiture of such shares) if conditions the
Administrator specifies in the Award Agreement are not satisfied before the end of the applicable restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant to Service Providers
Restricted Stock Units, which may be subject to vesting and forfeiture conditions during the applicable restriction period or periods, as set forth in an Award Agreement. The Administrator will determine and set forth in the Award Agreement the
terms and conditions for each Restricted Stock and Restricted Stock Unit Award, subject to the conditions and limitations contained in the Plan. 

6.2 Restricted Stock. 
 (a)
Dividends. Participants holding shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such Shares, unless the Administrator provides otherwise in the Award Agreement. In addition, unless the
Administrator provides otherwise, if any dividends or distributions are paid in Shares, or consist of a dividend or distribution to holders of Common Stock of property other than an ordinary cash dividend, the Shares or other property will be
subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with respect to which they were paid. 

(b) Stock Certificates. The Company may require that the Participant deposit in escrow with the Company (or its designee) any stock
certificates issued in respect of shares of Restricted Stock, together with a stock power endorsed in blank. 
 (c)
Section 83(b) Election. If a Participant makes an election under Section 83(b) of the Code to be taxed with respect to the Restricted Stock as of the date of transfer of the Restricted Stock rather than as of the date
or dates upon which such Participant would otherwise be taxable under Section 83(a) of the Code, such Participant shall be required to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue
Service along with proof of the timely filing thereof. 

  
 4 

 6.3 Restricted Stock Units. 

(a) Settlement. The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably
practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant’s election, in a manner intended to comply with Section 409A. 

(b) Stockholder Rights. A Participant will have no rights of a stockholder with respect to Shares subject to any Restricted Stock Unit
unless and until the Shares are delivered in settlement of the Restricted Stock Unit. 
 (c) Dividend Equivalents. If the
Administrator provides, a grant of Restricted Stock Units may provide a Participant with the right to receive Dividend Equivalents. Dividend Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares
and subject to the same restrictions on transferability and forfeitability as the Restricted Stock Units with respect to which the Dividend Equivalents are granted and subject to other terms and conditions as set forth in the Award Agreement. 

ARTICLE VII. 
 OTHER
STOCK OR CASH BASED AWARDS 
 7.1 Other Stock or Cash Based Awards may be granted to Participants, including Awards entitling
Participants to receive Shares to be delivered in the future and including annual or other periodic or long-term cash bonus awards (whether based on specified Performance Criteria or otherwise), in each case subject to any conditions and limitations
in the Plan. Such Other Stock or Cash Based Awards will also be available as a payment form in the settlement of other Awards, as standalone payments and as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock or
Cash Based Awards may be paid in Shares, cash or other property, as the Administrator determines. Subject to the provisions of the Plan, the Administrator will determine the terms and conditions of each Other Stock or Cash Based Award, including any
purchase price, performance goal (which may be based on the Performance Criteria), transfer restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement. 

ARTICLE VIII. 

ADJUSTMENTS FOR CHANGES IN COMMON STOCK 

AND CERTAIN OTHER EVENTS 

8.1 Equity Restructuring. In connection with any Equity Restructuring, notwithstanding anything to the contrary in this
Article VII, the Administrator will equitably adjust each outstanding Award as it deems appropriate to reflect the Equity Restructuring, which may include adjusting the number and type of securities subject to each outstanding Award and/or the
Award’s exercise price or grant price (if applicable), granting new Awards to Participants, and making a cash payment to Participants. The adjustments provided under this Section 8.1 will be nondiscretionary and final and binding on the
affected Participant and the Company; provided that the Administrator will determine whether an adjustment is equitable. 
 8.2 Corporate
Transactions. In the event of any dividend or other distribution (whether in the form of cash, Common Stock, other securities, or other property), reorganization, merger, consolidation, combination, amalgamation, repurchase, recapitalization,
liquidation, dissolution, or sale, transfer, exchange or other disposition of all or substantially all of the assets of the Company, or sale or exchange of Common Stock or other securities of the Company, Change in Control, issuance of warrants or
other rights to purchase Common Stock or other securities of the Company, other similar corporate transaction 

  
 5 

 
or event, other unusual or nonrecurring transaction or event affecting the Company or its financial statements or any change in any Applicable Laws or accounting principles, the Administrator, on
such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event (except that action to give effect to a change in Applicable Law or accounting principles may
be made within a reasonable period of time after such change) and either automatically or upon the Participant’s request, is hereby authorized to take any one or more of the following actions whenever the Administrator determines that such
action is appropriate in order to (x) prevent dilution or enlargement of the benefits or potential benefits intended by the Company to be made available under the Plan or with respect to any Award granted or issued under the Plan, (y) to
facilitate such transaction or event or (z) give effect to such changes in Applicable Laws or accounting principles: 
 (a) To provide
for the cancellation of any such Award in exchange for either an amount of cash or other property with a value equal to the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of
the Participant’s rights under the vested portion of such Award, as applicable; provided that, if the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the
Participant’s rights, in any case, is equal to or less than zero, then the Award may be terminated without payment; 
 (b) To provide
that such Award shall vest and, to the extent applicable, be exercisable as to all shares covered thereby, notwithstanding anything to the contrary in the Plan or the provisions of such Award; 

(c) To provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted
for by awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and/or applicable exercise or purchase price, in all cases, as determined
by the Administrator; 
 (d) To make adjustments in the number and type of shares of Common Stock (or other securities or property) subject
to outstanding Awards and/or with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article IV hereof on the maximum number and kind of shares which may be issued) and/or in
the terms and conditions of (including the grant or exercise price), and the criteria included in, outstanding Awards; 
 (e) To replace such
Award with other rights or property selected by the Administrator; and/or 
 (f) To provide that the Award will terminate and cannot vest, be
exercised or become payable after the applicable event. 
 8.3 Administrative Stand Still. In the event of any pending stock dividend,
stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other extraordinary transaction or change affecting the Shares or the share
price of Common Stock, including any Equity Restructuring or any securities offering or other similar transaction, for administrative convenience, the Administrator may refuse to permit the exercise of any Award for up to sixty days before or after
such transaction. 

  
 6 

 8.4 General. Except as expressly provided in the Plan or the Administrator’s
action under the Plan, no Participant will have any rights due to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class or dissolution, liquidation, merger, or
consolidation of the Company or other corporation. Except as expressly provided with respect to an Equity Restructuring under Section 8.1 above or the Administrator’s action under the Plan, no issuance by the Company of Shares of any
class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number of Shares subject to an Award or the Award’s grant or exercise price. The existence of the Plan, any Award Agreements
and the Awards granted hereunder will not affect or restrict in any way the Company’s right or power to make or authorize (i) any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its
business, (ii) any merger, consolidation dissolution or liquidation of the Company or sale of Company assets or (iii) any sale or issuance of securities, including securities with rights superior to those of the Shares or securities
convertible into or exchangeable for Shares. The Administrator may treat Participants and Awards (or portions thereof) differently under this Article VIII. 

ARTICLE IX. 
 GENERAL
PROVISIONS APPLICABLE TO AWARDS 
 9.1 Transferability. Except as the Administrator may determine or provide in an Award
Agreement or otherwise for Awards other than Incentive Stock Options, Awards may not be sold, assigned, transferred, pledged or otherwise encumbered, either voluntarily or by operation of law, except by will or the laws of descent and distribution,
or, subject to the Administrator’s consent, pursuant to a domestic relations order, and, during the life of the Participant, will be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, will
include references to a Participant’s authorized transferee that the Administrator specifically approves. 
 9.2 Documentation.
Each Award will be evidenced in an Award Agreement, which may be written or electronic, as the Administrator determines. Each Award may contain terms and conditions in addition to those set forth in the Plan. 

9.3 Discretion. Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award.
The terms of each Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly. 

9.4 Termination of Service; Change in Status. The Administrator will determine, in its sole discretion, the effect of all matters and
questions relating to any Termination of Service, including, without limitation, whether a Termination of Service has occurred, whether a Termination of Service resulted from a discharge for Cause and all questions of whether a particular leave of
absence constitutes a Termination of Service or any other change or purported change in a Participant’s Service Provider status affects an Award and the extent to which, and the period during which, the Participant, the Participant’s legal
representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award, if applicable. 
 9.5
Withholding. Each Participant must pay the Company, or make provision satisfactory to the Administrator for payment of, any taxes required by law to be withheld in connection with such Participant’s Awards by the date of the event
creating the tax liability. The Company may deduct an amount sufficient to satisfy such tax obligations based on the applicable statutory withholding rates (or such other rate as may be determined by the Company after considering any accounting
consequences or costs) from any payment of any kind otherwise due to a Participant. Subject to Section 10.8 and any Company insider trading policy (including blackout periods), Participants may satisfy such tax obligations (i) in cash, by
wire transfer of immediately available funds, by check made payable to the order of the Company, provided that the Company may limit the use of one of the foregoing payment forms if one or more of the payment forms below is permitted, (ii) to
the extent permitted by the Administrator, in whole or in part by delivery of Shares, including Shares retained from the Award creating the tax obligation, valued at their Fair Market 

  
 7 

 
Value, (iii) if there is a public market for Shares at the time the tax obligations are satisfied, unless the Company otherwise determines, (A) delivery (including telephonically to the
extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to satisfy the tax obligations, or (B) delivery by the Participant to the
Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to satisfy the tax withholding; provided that such amount is paid to the Company at
such time as may be required by the Administrator, or (iv) to the extent permitted by the Company, any combination of the foregoing payment forms approved by the Administrator. If any tax withholding obligation will be satisfied under clause
(ii) of the immediately preceding sentence by the Company’s retention of Shares from the Award creating the tax obligation and there is a public market for Shares at the time the tax obligation is satisfied, the Company may elect to
instruct any brokerage firm determined acceptable to the Company for such purpose to sell on the applicable Participant’s behalf some or all of the Shares retained and to remit the proceeds of the sale to the Company or its designee, and each
Participant’s acceptance of an Award under the Plan will constitute the Participant’s authorization to the Company and instruction and authorization to such brokerage firm to complete the transactions described in this sentence. 

9.6 Amendment of Award. The Administrator may amend, modify or terminate any outstanding Award, including by substituting another Award
of the same or a different type, changing the exercise or settlement date, and converting an Incentive Stock Option to a Non-Qualified Stock Option. The Participant’s consent to such action will be
required unless (i) the action, taking into account any related action, does not materially and adversely affect the Participant’s rights under the Award, or (ii) the change is permitted under Article VIII or pursuant to
Section 10.6. 
 9.7 Conditions on Delivery of Stock. The Company will not be obligated to deliver any Shares under the Plan or
remove restrictions from Shares previously delivered under the Plan until (i) all Award conditions have been met or removed to the Company’s satisfaction, (ii) as determined by the Company, all other legal matters regarding the
issuance and delivery of such Shares have been satisfied, including any applicable securities laws and stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such
representations or agreements as the Administrator deems necessary or appropriate to satisfy any Applicable Laws. The Company’s inability to obtain authority from any regulatory body having jurisdiction, which the Administrator determines is
necessary to the lawful issuance and sale of any securities, will relieve the Company of any liability for failing to issue or sell such Shares as to which such requisite authority has not been obtained. 

9.8 Acceleration. The Administrator may at any time provide that any Award will become immediately vested and fully or partially
exercisable, free of some or all restrictions or conditions, or otherwise fully or partially realizable. 
 9.9 Additional Terms of
Incentive Stock Options. The Administrator may grant Incentive Stock Options only to employees of the Company, any of its present or future parent or subsidiary corporations, as defined in Sections 424(e) or (f) of the Code,
respectively, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code. If an Incentive Stock Option is granted to a Greater Than 10% Stockholder, the exercise price will not be less than 110% of
the Fair Market Value on the Option’s grant date, and the term of the Option will not exceed five years. All Incentive Stock Options will be subject to and construed consistently with Section 422 of the Code. By accepting an Incentive
Stock Option, the Participant agrees if requested by the Company to give prompt notice to the Company of dispositions or other transfers (other than in connection with a Change in Control) of Shares acquired under the Option made within (i) two
years from the grant date of the Option or (ii) one year after the transfer of such Shares to the Participant, specifying the date of the disposition or other 

  
 8 

 
transfer and the amount the Participant realized, in cash, other property, assumption of indebtedness or other consideration, in such disposition or other transfer. Neither the Company nor the
Administrator will be liable to a Participant, or any other party, if an Incentive Stock Option fails or ceases to qualify as an “incentive stock option” under Section 422 of the Code. Any Incentive Stock Option or portion thereof
that fails to qualify as an “incentive stock option” under Section 422 of the Code for any reason, including becoming exercisable with respect to Shares having a fair market value exceeding the $100,000 limitation under Treasury
Regulation Section 1.422-4, will be a Non-Qualified Stock Option. 

ARTICLE X. 

MISCELLANEOUS 
 10.1 No
Right to Employment or Other Status. No person will have any claim or right to be granted an Award, and the grant of an Award will not be construed as giving a Participant the right to continued employment or any other relationship with the
Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement.

 10.2 No Rights as Stockholder; Certificates. Subject to the Award Agreement, no Participant or Designated Beneficiary will have any
rights as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding any other provision of the Plan, unless the Administrator otherwise determines or Applicable Laws
require, the Company will not be required to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded in the books of the Company (or, as applicable, its transfer agent or
stock plan administrator). The Company may place legends on stock certificates issued under the Plan that the Administrator deems necessary or appropriate to comply with Applicable Laws. 

10.3 Effective Date and Term of Plan. The Plan will become effective on the Pricing Date and, unless earlier terminated by the Board,
will remain in effect until the earlier of (i) the earliest date as of which all Awards granted under the Plan have been satisfied in full or terminated and no Shares approved for issuance under the Plan remain available to be granted under new
Awards or (ii) the tenth anniversary of the date the Board adopted the Plan, but Awards previously granted may extend beyond that date in accordance with the Plan. If the Plan is not approved by the Company’s stockholders, the Plan will
not become effective and no Awards will be granted under the Plan. 
 10.4 Amendment of Plan. The Administrator may amend, suspend or
terminate the Plan at any time; provided that no amendment, other than an increase to the Overall Share Limit, may materially and adversely affect any Award outstanding at the time of such amendment without the affected Participant’s consent.
No Awards may be granted under the Plan during any suspension period or after Plan termination. Awards outstanding at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect
before such suspension or termination. The Board will obtain stockholder approval of any Plan amendment to the extent necessary to comply with Applicable Laws. 

10.5 Provisions for Foreign Participants. The Administrator may modify Awards granted to Participants who are foreign nationals or
employed outside the United States or establish subplans or procedures under the Plan to address differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other
matters. 

  
 9 

 10.6 Section 409A. 

(a) General. The Company intends that all Awards be structured to comply with, or be exempt from, Section 409A, such that no
adverse tax consequences, interest, or penalties under Section 409A apply. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without a Participant’s consent, amend this Plan or Awards,
adopt policies and procedures, or take any other actions (including amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including any such actions intended to
(A) exempt this Plan or any Award from Section 409A, or (B) comply with Section 409A, including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award’s grant date.
The Company makes no representations or warranties as to an Award’s tax treatment under Section 409A or otherwise. The Company will have no obligation under this Section 10.6 or otherwise to avoid the taxes, penalties or interest
under Section 409A with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan are determined to constitute noncompliant “nonqualified deferred
compensation” subject to taxes, penalties or interest under Section 409A. 
 (b) Separation from Service. If an Award
constitutes “nonqualified deferred compensation” under Section 409A, any payment or settlement of such Award upon a termination of a Participant’s Service Provider relationship will, to the extent necessary to avoid taxes under
Section 409A, be made only upon the Participant’s “separation from service” (within the meaning of Section 409A), whether such “separation from service” occurs upon or after the Termination of Service of a
Participant. For purposes of this Plan or any Award Agreement relating to any such payments or benefits, references to a “termination,” “termination of employment,” Termination of Service or like terms means a “separation
from service.” 
 (c) Payments to Specified Employees. Notwithstanding any contrary provision in the Plan or any Award Agreement,
any payment(s) of “nonqualified deferred compensation” required to be made under an Award to a “specified employee” (as defined under Section 409A and as the Administrator determines) due to his or her “separation from
service” will, to the extent necessary to avoid taxes under Section 409A(a)(2)(B)(i) of the Code, be delayed for the six-month period immediately following such “separation from service”
(or, if earlier, until the specified employee’s death) and will instead be paid (as set forth in the Award Agreement) on the day immediately following such six-month period or as soon as administratively
practicable thereafter (without interest). Any payments of “nonqualified deferred compensation” under such Award payable more than six months following the Participant’s “separation from service” will be paid at the time or
times the payments are otherwise scheduled to be made. 
 10.7 Limitations on Liability. Notwithstanding any other provisions of the
Plan, no individual acting as a director, officer, other employee or agent of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense
incurred in connection with the Plan or any Award, and such individual will not be personally liable with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director, officer, other
employee or agent of the Company or any Subsidiary. The Company will indemnify and hold harmless each director, officer, other employee and agent of the Company or any Subsidiary that has been or will be granted or delegated any duty or power
relating to the Plan’s administration or interpretation, against any cost or expense (including attorneys’ fees) or liability (including any sum paid in settlement of a claim with the Administrator’s approval) arising from any act or
omission concerning this Plan unless arising from such person’s own fraud or bad faith. 
 10.8
Lock-Up Period. The Company may, at the request of any underwriter representative or otherwise, in connection with registering the offering of any Company securities under the Securities Act, prohibit
Participants from, directly or indirectly, selling or otherwise transferring any Shares or other Company securities during a period of up to one hundred eighty days following the effective date of a Company registration statement filed under the
Securities Act, or such longer period as determined by the underwriter. 

  
 10 

 10.9 Data Privacy. As a condition for receiving any Award, each Participant
explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of personal data as described in this section by and among the Company and its Subsidiaries and affiliates exclusively for implementing,
administering and managing the Participant’s participation in the Plan. The Company and its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant’s name, address and telephone
number; birthdate; social security, insurance number or other identification number; salary; nationality; job title(s); any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the
Plan and Awards (the “Data”). The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves as necessary to implement, administer and manage a Participant’s participation in the Plan, and the
Company and its Subsidiaries and affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These recipients may be located in the Participant’s country, or elsewhere, and
the Participant’s country may have different data privacy laws and protections than the recipients’ country. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain and transfer the Data, in
electronic or other form, to implement, administer and manage the Participant’s participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant may elect to deposit any
Shares. The Data related to a Participant will be held only as long as necessary to implement, administer, and manage the Participant’s participation in the Plan. A Participant may, at any time, view the Data that the Company holds regarding
such Participant, request additional information about the storage and processing of the Data regarding such Participant, recommend any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this
Section 10.9 in writing, without cost, by contacting the local human resources representative. The Company may cancel Participant’s ability to participate in the Plan and, in the Administrator’s discretion, the Participant may forfeit
any outstanding Awards if the Participant refuses or withdraws the consents in this Section 10.9. For more information on the consequences of refusing or withdrawing consent, Participants may contact their local human resources representative.

 10.10 Severability. If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the
illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void. 

10.11 Governing Documents. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a
Participant and the Company (or any Subsidiary) that the Administrator has approved, the Plan will govern, unless it is expressly specified in such Award Agreement or other written document that a specific provision of the Plan will not apply. 

10.12 Governing Law. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the State of Delaware,
disregarding any state’s choice-of-law principles requiring the application of a jurisdiction’s laws other than the State of Delaware. 

10.13 Claw-back Provisions. All Awards (including any proceeds, gains or other economic benefit the Participant actually or
constructively receives upon receipt or exercise of any Award or the receipt or resale of any Shares underlying the Award) will be subject to any Company claw-back policy, including any claw-back policy adopted to comply with Applicable Laws
(including the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder) as set forth in such claw-back policy or the Award Agreement. 

  
 11 

 10.14 Titles and Headings. The titles and headings in the Plan are for convenience of
reference only and, if any conflict, the Plan’s text, rather than such titles or headings, will control. 
 10.15 Conformity to
Securities Laws. Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Laws. Notwithstanding anything herein to the contrary, the Plan and all Awards will be administered only in conformance with
Applicable Laws. To the extent Applicable Laws permit, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Laws. 

10.16 Relationship to Other Benefits. No payment under the Plan will be taken into account in determining any benefits under any
pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except as expressly provided in writing in such other plan or an agreement thereunder. 

10.17 Broker-Assisted Sales. In the event of a broker-assisted sale of Shares in connection with the payment of amounts owed by a
Participant under or with respect to the Plan or Awards, including amounts to be paid under the final sentence of Section 9.5: (a) any Shares to be sold through the broker-assisted sale will be sold on the day the payment first becomes due, or
as soon thereafter as practicable; (b) such Shares may be sold as part of a block trade with other Participants in the Plan in which all participants receive an average price; (c) the applicable Participant will be responsible for all
broker’s fees and other costs of sale, and by accepting an Award, each Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale; (d) to the extent the Company or
its designee receives proceeds of such sale that exceed the amount owed, the Company will pay such excess in cash to the applicable Participant as soon as reasonably practicable; (e) the Company and its designees are under no obligation to
arrange for such sale at any particular price; and (f) in the event the proceeds of such sale are insufficient to satisfy the Participant’s applicable obligation, the Participant may be required to pay immediately upon demand to the
Company or its designee an amount in cash sufficient to satisfy any remaining portion of the Participant’s obligation. 
 ARTICLE XI.

 DEFINITIONS 
 As
used in the Plan, the following words and phrases will have the following meanings: 
 11.1 “Administrator” means the
Board or a Committee to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee. 
 11.2
“Applicable Laws” means the requirements relating to the administration of equity incentive plans under U.S. federal and state securities, tax and other applicable laws, rules and regulations, the applicable rules of any
stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws and rules of any foreign country or other jurisdiction where Awards are granted. 

11.3 “Award” means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights,
Restricted Stock, Restricted Stock Units or Other Stock or Cash Based Awards. 

  
 12 

 11.4 “Award Agreement” means a written agreement evidencing an
Award, which may be electronic, that contains such terms and conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan. 

11.5 “Board” means the Board of Directors of the Company. 

11.6 “Cause” means (i) if a Participant is a party to a written employment, severance or consulting agreement with
the Company or any of its Subsidiaries or an Award Agreement in which the term “cause” is defined (a “Relevant Agreement”), “Cause” as defined in the Relevant Agreement, and (ii) if no Relevant
Agreement exists, (A) conviction of any felony, or the conviction of a misdemeanor which involves moral turpitude, or the entry of a plea of guilty or nolo cotendere with respect to any of the foregoing, (B) the commission of any
act of failure to act that involves moral turpitude, dishonesty, theft, destruction of property, fraud, embezzlement or unethical business conduct, or that otherwise causes material injury to the Company or any of its Affiliates, whether financially
or otherwise, (C) any breach of any rule or policy of the Company or any of its Affiliates, and the failure to cure such violation (to the extent such violation is capable of being cured) under this clause (C) within twenty (20) days
after receipt of written from the Company, or (D) any breach of the requirements of any other contract or agreement between the Company (or any of its Affiliates) and such Person, including such Person’s Relevant Agreement, and the failure
of such Person to cure such breach (to the extent such breach is capable of being cured) under this clause (D) within ten (10) days after receipt of written notice from the Company, in each case, with respect to clauses (A) through
(D), as determined in good faith by the Board in the exercise of its reasonable business judgment. 
 11.7 “Change in
Control” means and includes each of the following: 
 (a) A transaction or series of transactions (other than an offering of
Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that meets the requirements of clauses (i) and (ii) of subsection (c) below)
whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its Subsidiaries, an employee benefit plan maintained
by the Company or any of its Subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership
(within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50 % of the total combined voting power of the Company’s securities outstanding immediately
after such acquisition; or 
 (b) During any period of two consecutive years, individuals who, at the beginning of such period, constitute
the Board together with any new Director(s) (other than a Director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in subsections (a) or (c) whose election by the Board or
nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the Directors then still in office who either were Directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or 

(c) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more
intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions
or (z) the acquisition of assets or stock of another entity, in each case other than a transaction: 

  
 13 

 (i) which results in the Company’s voting securities outstanding immediately before
the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly
or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of
the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 
 (ii) after
which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this clause
(ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction. 

Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Award (or portion of any Award) that
provides for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition of additional taxes under Section 409A, the transaction or event described in subsection (a), (b) or
(c) with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a “change in control event,” as defined in Treasury
Regulation Section 1.409A-3(i)(5). 
 The Administrator shall have full and final authority,
which shall be exercised in its discretion, to determine conclusively whether a Change in Control has occurred pursuant to the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto;
provided that any exercise of authority in conjunction with a determination of whether a Change in Control is a “change in control event” as defined in Treasury Regulation Section 1.409A-3(i)(5)
shall be consistent with such regulation. 
 11.8 “Code” means the Internal Revenue Code of 1986, as amended, and the
regulations issued thereunder. 
 11.9 “Committee” means one or more committees or subcommittees of the Board, which
may include one or more Company directors or executive officers, to the extent Applicable Laws permit. To the extent required to comply with the provisions of Rule 16b-3, it is intended that each member of the
Committee will be, at the time the Committee takes any action with respect to an Award that is subject to Rule 16b-3, a “non-employee director” within the
meaning of Rule 16b-3; however, a Committee member’s failure to qualify as a “non-employee director” within the meaning of Rule 16b-3 will not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan. 

11.10 “Common Stock” means common stock of the Company. 

11.11 “Company” means WCG Clinical, Inc., a Delaware corporation, or any successor. 

11.12 “Consultant” means any person, including any adviser, engaged by the Company or its parent or Subsidiary to
render services to such entity if the consultant or adviser: (i) renders bona fide services to the Company; (ii) renders services not in connection with the offer or sale of securities in a capital-raising transaction and does not directly
or indirectly promote or maintain a market for the Company’s securities; and (iii) is a natural person. 

  
 14 

 11.13 “Designated Beneficiary” means the beneficiary or
beneficiaries the Participant designates, in a manner the Administrator determines, to receive amounts due or exercise the Participant’s rights if the Participant dies or becomes incapacitated. Without a Participant’s effective
designation, “Designated Beneficiary” will mean the Participant’s estate. 
 11.14 “Director” means a
Board member. 
 11.15 “Disability” means a condition entitling the Participant to receive benefits under a long-term
disability plan of the Company or Subsidiary of the Company in which the Participant is eligible to participate, or, in the absence of such plan, the Participant’s complete and permanent inability by reason of illness or accident to materially
perform the duties of the occupation at which the Participant is employed or served when such disability commenced. Any determination of whether Disability exists shall be made by the Company (or its designee) in good faith, in its sole and absolute
discretion. 
 11.16 “Dividend Equivalents” means a right granted to a Participant under the Plan to receive the
equivalent value (in cash or Shares) of dividends paid on Shares. 
 11.17 “Employee” means any employee of the
Company or its Subsidiaries. 
 11.18 “Equity Restructuring” means a nonreciprocal transaction between the Company
and its stockholders, such as a stock dividend, stock split, spin-off or recapitalization through a large, nonrecurring cash dividend, that affects the number or kind of Shares (or other Company securities) or
the share price of Common Stock (or other Company securities) and causes a change in the per share value of the Common Stock underlying outstanding Awards. 

11.19 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

11.20 “Exchange Program” shall mean a program under which (i) outstanding Awards are surrendered or cancelled in
exchange for Awards of the same type (which may have higher or lower exercise prices and different terms), Awards of a different type, and/or cash, (ii) Holders would have the opportunity to transfer any outstanding Awards to a financial
institution or other person or entity selected by the Administrator, and/or (iii) the exercise price of an outstanding Award is reduced or increased. The Administrator will determine the terms and conditions of any Exchange Program in its sole
discretion. 
 11.21 “Fair Market Value” means, as of any date, the value of Common Stock determined as follows:
(i) if the Common Stock is listed on any established stock exchange, its Fair Market Value will be the closing sales price for such Common Stock as quoted on such exchange for such date, or if no sale occurred on such date, the last day
preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; (ii) if the Common Stock is not traded on a stock exchange but is quoted on a national market or other
quotation system, the closing sales price on such date, or if no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems
reliable; or (iii) in any case the Administrator may determine the Fair Market Value in its discretion. 

  
 15 

 11.22 “Greater Than 10% Stockholder” means an individual then owning
(within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all classes of stock of the Company or its parent or subsidiary corporation, as defined in Section 424(e) and (f) of the Code,
respectively. 
 11.23 “Incentive Stock Option” means an Option intended to qualify as an “incentive stock
option” as defined in Section 422 of the Code. 
 11.24 “Non-Qualified Stock
Option” means an Option not intended or not qualifying as an Incentive Stock Option. 
 11.25 “Option”
means an option to purchase Shares. 
 11.26 “Other Stock or Cash Based Awards” means cash awards, awards of Shares,
and other awards valued wholly or partially by referring to, or are otherwise based on, Shares or other property. 
 11.27
“Overall Share Limit” means the sum of (i) 37,918,905 Shares; and (ii) an annual increase on the first day of each calendar year beginning January 1, 2022 and ending on and including January 1, 2031, equal to
the lesser of (A) 5% of the aggregate number of shares of Common Stock outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of Shares as is determined by the Board. 

11.28 “Participant” means a Service Provider who has been granted an Award. 

11.29 “Performance Criteria” mean the criteria (and adjustments) that the Administrator may select for an Award to
establish performance goals for a performance period, which may include the following: net earnings or losses (either before or after one or more of interest, taxes, depreciation, amortization, and non-cash
equity-based compensation expense); gross or net sales or revenue or sales or revenue growth; net income (either before or after taxes) or adjusted net income; profits (including but not limited to gross profits, net profits, profit growth, net
operation profit or economic profit), profit return ratios or operating margin; budget or operating earnings (either before or after taxes or before or after allocation of corporate overhead and bonus); cash flow (including operating cash flow and
free cash flow or cash flow return on capital); return on assets; return on capital or invested capital; cost of capital; return on stockholders’ equity; total stockholder return; return on sales; costs, reductions in costs and cost control
measures; expenses; working capital; earnings or loss per share; adjusted earnings or loss per share; price per share or dividends per share (or appreciation in or maintenance of such price or dividends); regulatory achievements or compliance;
implementation, completion or attainment of objectives relating to research, development, regulatory, commercial, or strategic milestones or developments; market share; economic value or economic value added models; division, group or corporate
financial goals; customer satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation and other legal matters; strategic partnerships and transactions;
financial ratios (including those measuring liquidity, activity, profitability or leverage); debt levels or reductions; sales-related goals; financing and other capital raising transactions; cash on hand; acquisition activity; investment sourcing
activity; marketing initiatives; and other measures of performance selected by the Board or Committee whether or not listed herein, any of which may be measured in absolute terms or as compared to any incremental increase or decrease. Such
performance goals also may be based solely by reference to the Company’s performance or the performance of a Subsidiary, division, business segment or business unit of the Company or a Subsidiary, or based upon performance relative to 

  
 16 

 
performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. The Committee may provide for exclusion of the impact of an
event or occurrence which the Committee determines should appropriately be excluded, including (a) restructurings, discontinued operations, extraordinary items, and other unusual, infrequently occurring or
non-recurring charges or events, (b) asset write-downs, (c) litigation or claim judgments or settlements, (d) acquisitions or divestitures, (e) reorganization or change in the corporate
structure or capital structure of the Company, (f) an event either not directly related to the operations of the Company, Subsidiary, division, business segment or business unit or not within the reasonable control of management,
(g) foreign exchange gains and losses, (h) a change in the fiscal year of the Company, (i) the refinancing or repurchase of bank loans or debt securities, (j) unbudgeted capital expenditures, (k) the issuance or repurchase
of equity securities and other changes in the number of outstanding shares, (l) conversion of some or all of convertible securities to Common Stock, (m) any business interruption event (n) the cumulative effects of tax or accounting
changes in accordance with U.S. generally accepted accounting principles, or (o) the effect of changes in other laws or regulatory rules affecting reported results. 

11.30 “Plan” means this 2021 Incentive Award Plan. 

11.31 “Pricing Date” means the date upon which the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission relating to the registered underwritten public offering of shares of Common Stock becomes effective. 

11.32 “Restricted Stock” means Shares awarded to a Participant under Article VI subject to certain vesting
conditions and other restrictions. 
 11.33 “Restricted Stock Unit” means an unfunded, unsecured right to receive, on
the applicable settlement date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement date, subject to certain vesting conditions and other restrictions. 

11.34 “Rule 16b-3” means Rule 16b-3
promulgated under the Exchange Act. 
 11.35 “Section 409A” means Section 409A
of the Code and all regulations, guidance, compliance programs and other interpretative authority thereunder. 
 11.36 “Securities
Act” means the Securities Act of 1933, as amended. 
 11.37 “Service Provider” means an Employee,
Consultant or Director. 
 11.38 “Shares” means shares of Common Stock. 

11.39 “Stock Appreciation Right” means a stock appreciation right granted under Article V. 

11.40 “Subsidiary” means any entity (other than the Company), whether domestic or foreign, in an unbroken chain of
entities beginning with the Company if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or interests representing at least 50% of the total combined voting power of
all classes of securities or interests in one of the other entities in such chain. 
 11.41 “Substitute Awards” shall
mean Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, awards previously granted, or the right or obligation to make future awards, in each case by a company acquired by the Company or any
Subsidiary or with which the Company or any Subsidiary combines. 

  
 17 

 11.42 “Termination of Service” means the date the Participant ceases
to be a Service Provider. 
 * * * * * 

  
 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]